Evaluation of single layer amniotic membrane in the management of nonhealing diabetic foot ulcers: an interim analysis of CAMPX
DOI:
https://doi.org/10.63676/m04r0s60Keywords:
interim analysis, diabetic foot ulcer, chronic wounds, tissue regeneration, clinical trial designAbstract
Background: Diabetic foot ulcers (DFUs) represent a chronic and debilitating complication of diabetes, contributing substantially to patient morbidity, mortality, and economic burden. Despite advances in clinical management, outcomes with the current standard of care (SOC) remain suboptimal, with many ulcers failing to achieve complete closure. These limitations reinforce the need for innovative, cost-effective solutions that promote wound closure.
Methods: This randomized controlled multicenter clinical trial evaluated the efficacy of single layer amniotic membrane (SLAM) plus SOC versus SOC alone in achieving complete closure of nonhealing DFUs over 12 weeks. The primary endpoint was complete wound closure, defined as 100% re-epithelialization without drainage for two consecutive weeks, confirmed by blinded independent review.
Results: In Intent-To-Treat (ITT), the SLAM + SOC arm achieved a 13.1% closure rate versus 8.8% with SOC alone, with findings consistent in the Per-Protocol (PP) population. Additionally, the percent area reduction (PAR) from TV-1 to TV-13 measured weekly with digital photographic planimetry and physical examination were analyzed. For ITT, SLAM + SOC outperformed SOC on both average and median wound‐area reduction.
Conclusion: The interim analysis demonstrated that wounds managed with SLAM products trended toward superiority over those managed with SOC.
References
1. International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium: 2021. Available at: https://www.diabetesatlas.org.
2. Wu Y, Ding Y, Tanaka Y, Zhang W. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014; 11(11); 1185-200. https://doi.org/10.7150/ijms.10001
3. McDermott K, Fang M, Boulton AJM, Selvin E, Hicks CW. Etiology, epidemiology, and disparities in the burden of dia-betic foot ulcers. Diabetes Care 2023; 46(1): 209-221. https://doi.org/10.2337/dci22-0043
4. Game F. Classification of diabetic foot ulcers. Diabetes/Metabolism Res Rev. 2016;32(1): 186-94. https://doi.org/10.1002/dmrr.2746
5. Alsanawi Y, Alismail H, AlabdRabalnabi M, Alturki H, Alsuhaibani A, Mahbub M, Aldaghmani M. Pathogenesis and management of diabetic foot ulcers. Int J Community Med Pub Health. 2018; 5(11), 4953. https://doi.org/10.18203/2394-6040.ijcmph20184249
6. Hoffstad O, Mitra N, Walsh J, Margolis DJ. Diabetes, lower-extremity amputation, and death. Diabetes Care. 2015; 38(10), 1852–1857. https://doi.org/10.2337/dc15-0536
7. Geiss LS, Li Y, Hora I, Albright A, Rolka D, Gregg EW. Resurgence of diabetes-related nontraumatic lower-extremity amputation in the young and middle-aged adult U.S. population. Diabetes Care, 2018; 42(1), 50–54. https://doi.org/10.2337/dc18-1380
8. Harding JL, Andes LJ, Rolka DB, Imperatore G, Gregg EW, Li Y, Albright A. National and state-level trends in non-traumatic lower-extremity amputation among U.S. medicare beneficiaries with diabetes, 2000–2017. Diabetes Care. 2020, 43(10), 2453–2459. https://doi.org/10.2337/dc20-0586
9. Armstrong, David G et al. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J Foot Ankle Res 2020; 13,1(16); 24., https://doi.org/10.1186/s13047-020-00383-2
10. Fife CE, Eckert KA, Carter MJ. Publicly reported wound healing rates: the fantasy and the reality. Adv Wound Care (New Rochelle). 2018; 1;7(3):77-94. https://doi.org/10.1089/wound.2017.0743
11. Lim JZM, Ng NSL, Thomas C. Prevention and treatment of diabetic foot ulcers. J Royal Society Med 2017; 110,3: 104-109. https://doi.org/10.1177/0141076816688346
12. Ha, Jeong Hyun et al. Association between socioeconomic position and diabetic foot ulcer outcomes: a population-based cohort study in South Korea. BMC Public Health. 2021; 21(1)1395. https://doi.org/10.1186/s12889-021-11406-3
13. Armstrong DG, Kanda GA, Lavery LA et al. Mind the gap: disparity between research funding and costs of care for di-abetic foot ulcers. Diabetes Care 2013; 36,7: 1815-7. https://doi.org/10.2337/dc12-2285
14. Wu, Stephanie et al. Best practice for wound repair and regeneration use of cellular, acellular and matrix-like products (CAMPs). J Wound Care. 2023; 32,Sup4b: S1-S31. https://doi.org/10.12968/jowc.2023.32.Sup4b.S1
15. Almeida GH, Rinaldi J, de Calomeno, CV, Prado MB et al. Unlocking the regenerative properties of extraembryonic membrane-derived biomaterials in tissue engineering. Acta Biomaterialia, 2025; 203, 94–134. https://doi.org/10.1016/j.actbio.2025.07.028
16. Serena TE, Tramelli B, King E, Maloumi S. A multicentre, prospective, randomized controlled modified platform trial evaluating purion processed lyophilized human amnion/chorion membrane and standard of care versus standard of care alone in the treatment of non-healing diabetic foot ulcers. Int J Tissue Repair 2025; 1(1). https://doi.org/10.63676/ctkc9r79
17. Oltmann M, Kyle D, Gilbert TJ, Devlin C et al. Clinical outcomes of lyophilised human amnion/chorion membrane in treatment of hard-to-heal diabetic foot ulcers in complex cases: A case series. J Wound Care; 2025; 34(3), 187–194. https://doi.org/10.12968/jowc.2025.0022
18. Tettelbach W, Cazzell S, Reyzelman AM et al. A confirmatory study on the efficacy of dehydrated human amni-on/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, random-ised, controlled study of 110 patients from 14 wound clinics. Int Wound Journal. 2019; 16(1), 19–29. https://doi.org/10.1111/iwj.12976
19. Tettelbach W, Cazzell S, Sigal F et al. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers. Int Wound Journal. 2019; 16(1), 122–130. https://doi.org/10.1111/iwj.13001
Downloads
Published
Data Availability Statement
The data is proprietary but is available on request to the corresponding author.
Issue
Section
License
Copyright (c) 2025 International Journal of Tissue Repair
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
